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Abstract
Background: Genome-wide association studies (GWAS) in populations of European ancestry have mapped a type 2 diabetes
susceptibility region to chromosome 10q23.33 containing IDE, KIF11 and HHEX genes (IDE-KIF11-HHEX), which has also been
replicated in Chinese populations. However, the functional relevance for genetic variants at this locus is still unclear. It is
critical to systematically assess the relationship of genetic variants in this region with the risk of type 2 diabetes.
Methodology/Principal Findings: A fine-mapping study was conducted by genotyping fourteen tagging single-nucleotide
polymorphisms (SNPs) in a 290-kb linkage disequilibrium (LD) region using a two-stage case-control study of type 2
diabetes in a Chinese Han population. Suggestive associations (P,0.05) observed from 1,200 cases and 1,200 controls in the
first stage were further replicated in 1,725 cases and 2,081 controls in the second stage. Seven tagging SNPs were
consistently associated with type 2 diabetes in both stages (P,0.05), with combined odds ratios (ORs) ranging from 1.14 to
1.33 in the combined analysis. The most significant locus was rs7923837 [OR=1.33, 95% confidence interval (CI): 1.21–1.47]
at the 39-flanking region of HHEX gene. SNP rs1111875 was found to be another partially independent locus (OR=1.23, 95%
CI: 1.13–1.35) in this region that was associated with type 2 diabetes risk. A cumulative effect of rs7923837 and rs1111875
was observed with individuals carrying 1, 2, and 3 or 4 risk alleles having a 1.27, 1.44, and 1.73-fold increased risk,
respectively, for type 2 diabetes (P for trend=4.1E-10).
Conclusions/Significance: Our results confirm that genetic variants of the IDE-KIF11-HHEX region at 10q23.33 contribute to
type 2 diabetes susceptibility and suggest that rs7923837 may represent the strongest signal related to type 2 diabetes risk
in the Chinese Han population.
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Introduction
Type 2 diabetes is one of major public health problems around
the world with an affected number of 240 million in 2007, with an
expected rapid increase to 380 million by 2025 [1]. In China,
about 92.4 million adults ($20 years old) are affected with diabetes
while about 148.2 million adults are in a status of prediabetes [2].
Type 2 diabetes is a serious metabolic disorder, characterized by
insulin resistance and relative insulin deficiency, which results from
both genetic and environmental factors. The increasing prevalence
of type 2 diabetes is largely attributed to environmental factors
acting on genetically susceptible individuals. Therefore, it is
important to understand the susceptibility genes for type 2 diabetes
to facilitate risk assessment, primary prevention, early detection
and treatment.
Genome-wide association study (GWAS) has made spectacular
progress in identifying susceptibility genes involved in type 2
diabetes. In 2007, the first GWAS of type 2 diabetes conducted in
a French case-control cohort identified a type 2 diabetes related
locus on chromosome 10q23.33, which is located in a gene cluster
including the insulin-degrading enzyme (IDE), the kinesin-
interacting factor 11 (KIF11), and the hematopoietically expressed
homeobox (HHEX) [3]. This association has been consistently
replicated in the subsequent studies [4–9], including several studies
in Chinese populations [10–17]. HHEX encodes a transcription
factor with a key role for pancreatic development [18]. Reduction
of IDE activity by a pharmacological inhibitor increases islet
amyloid polypeptide (amylin) accumulation and amylin-mediated
cytotoxicity in cultured b-cells [19], whereas IDE ablation causes
glucose intolerance in knockout mice [20]. Therefore, both IDE
and HHEX genes are strong candidates as susceptibility genes
modulating the pathogenesis of type 2 diabetes.
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35060The IDE-KIF11-HHEX locus spans a 290 kb region in linkage
equilibrium (LD) (Figure S1). Two variants at the 39-flanking
region of the HHEX gene, rs7923837 and rs1111875, have been
associated with type 2 diabetes risk as lead single-nucleotide
polymorphisms (SNPs) in original GWAS in populations of
European ancestry. These two SNPs do not reside within the
coding or putative regulatory regions of any known genes. It is still
an open topic which variant(s) at IDE-KIF11-HHEX locus is (are)
causal, especially in different populations. Herein, with the aim to
systematically evaluate the relationship between genetic variants at
10q23.33 and type 2 diabetes risk and provide evidence for causal
variant(s) in this gene region, we conducted a fine-mapping study
including 14 tagging SNPs at 10q23.33 in a large, two-stage case-
control study with a total of 2,925 cases and 3,281 controls in a
Chinese population.
Methods
Ethics statement
This study was approved by the Ethical Committee of Nanjing
Medical University. Written informed consent was obtained from
each participant before investigation.
Study population
In this study, we performed a two-stage case-control study. The
first-stage (discovery-phase) fine-mapping analysis was designed to
discover the suggestive variants associated with type 2 diabetes in a
Chinese population consisting of 1,200 cases and 1,200 controls
from a community based cohort study of type 2 diabetes in Wuxi,
a city of southern Jiangsu Province, China. In this study, eligible
subjects aged over 30 years old were enrolled in 2007 and the
baseline information, including demographic, disease history,
family history of diabetes was obtained and a detailed clinical
examination was conducted. Anthropometric variables including
height, weight, waist and hip circumference and blood pressure
were measured. Body mass index (BMI) was calculated as weight
(in kilograms) divided by the square of height (in meters). Ten
hours overnight fasting blood samples were drawn for measure-
ments of fasting blood glucose (FBG) and lipids in all subjects.
Glucose concentration and lipids were measured on an OLYM-
PUS (C2734-Au640) automatic analyzer in the central laboratory
of Wuxi Center for Disease Control and Prevention, which was
authorized to perform laboratory tests according to the interna-
tional quality standard ISO/IEC 17025. At baseline, 1,200
subjects who had a history of type 2 diabetes and were on
medical treatment for type 2 diabetes were selected as type 2
diabetes cases. The control subjects were selected from those
without history of diabetes, hypertension, coronary heart disease,
stroke, cancer and with a FBG,5.6 mmol/l at both baseline and
follow-up in 2009 and were frequency-matched to the cases on sex
(n=1,200).
The second-stage (replication-phase) was to confirm the results
observed in the first-stage, and consisted of 1,725 cases and 2,081
controls derived from a community-based cross-sectional survey
on chronic non-communicable diseases in 2009 in Nantong, a city
in middle Jiangsu Province, China. All study participants aged
over 30 years were interviewed face-to-face by trained interviewers
using a pre-tested questionnaire including demographic, behav-
iors, disease history, and family history of diabetes. Anthropomet-
ric parameters and blood pressure were measured. Over 10-hour
fasting blood samples were collected for measurement of blood
glucose and lipids. Subjects were considered to have type 2
diabetes if they had a history of type 2 diabetes or if their fasting
glucose was 7.0 mmol/l or higher. Eventually, 1,725 subjects were
recruited as cases. Meanwhile, we selected 2,081 subjects without
history of diabetes, hypertension, coronary heart disease, stroke,
cancer and with FBG,5.6 mmol/l as controls from the same
population and also frequency-matched to the cases on sex.
Individuals with the following conditions were excluded from
the study at both stages: malnutrition (BMI,18.5 kg/m
2); physical
disabilities or psychological disorder; obesity caused by other
diseases (such as islet cell tumor, Cushing’s syndrome, polycystic
ovary syndrome, hypogonadism, hypothyroidism) or by medica-
tion (such as glucocorticoid, oral contraceptive); cancer; current
diagnosis of any communicable disease. All subjects in this study
were unrelated ethnic Han Chinese. All blood specimens were
stored at the Key Molecular Epidemiology Laboratory, Depart-
ment of Epidemiology and Biostatistics, School of Public Health,
Nanjing Medical University. Genomic DNA was extracted from a
leukocyte pellet by proteinase K digestion and was followed by
phenol-chloroform extraction and ethanol precipitation.
SNPs selection
We selected both potentially functional SNPs and haplotype-
tagging SNPs (htSNP) in the IDE-KIF11-HHEX locus at 10q23.33
(chr10:94199856–94489557). Firstly, to infer potentially functional
SNPs, we searched common (MAF$0.10) SNPs located in the 59-
flanking region, 59untranslated region (59UTR), exon, and 39UTR
of IDE, KIF11 and HHEX genes using NCBI dbSNP database and
8 SNPs (rs7078243, rs1044153, rs11595187, rs11187083,
rs2297743, rs3758505, rs7099761, rs4646954) were found. As
there isn’t any information on rs1044153, rs7099761, rs4646954
in HapMap database, we conducted LD analysis on the other 5
SNPs (rs7078243,rs11595187, rs11187083, rs2297743,
rs3758505). Among them, 3 SNPs (rs2297743, rs7078243,
rs11187083) were finally selected for this study, because the other
2 SNPs (rs3758505 and rs11595187) are in high LD with
rs2297743 (r
2=0.97 and r
2=0.96, respectively). Secondly, we
directly included three SNPs (rs1111875, rs5015480, rs7923837)
which were significantly associated with type 2 diabetes risk in
previous GWAS.
Then we used the block-based tagging strategy to find tagging
SNPs using Haploview 4.2 software according to the HapMap
database (http://www.hapmap.org/, phaseII Nov08, on NCBI
B36 assembly, dbSNP b126; population: Chinese Han population
(CHB) and Japanese population (JPT)); MAF$0.10, Hardy-
Weinberg equilibrium P$0.05 and call rate $95%) on the basis
of pairwise LD r
2 threshold of 0.8. After forced including the
above 6 SNPs (rs2297743, rs7078243, rs11187083, rs1111875,
rs5015480, rs7923837) as tagging SNPs into Haploview software,
the additional 13 SNPs (rs11187096, rs4646957, rs7911264,
rs2488073, rs947591, rs10882084, rs11187146, rs7910605,
rs2488075, rs7918084, rs11187094, rs6583826, rs4933236) that
met the above criteria in this IDE-KIF11-HHEX region were
selected. As a result, a total of 19 SNPs were selected for
genotyping in the discovery stage (Figure S1).
Genotype determination
In the discovery stage, genotyping was performed using the
TaqMan OpenArray Genotyping System (Life Technologies,
Carlsbad, USA), a medium-throughput genotyping platform.
DNA samples with standardized concentration were loaded and
amplified on 48-sample arrays following the manufacturer’s
protocol. For quality control, the equal amounts of cases and
controls and two no template controls (NTCs) were simultaneously
detected in each chip. Four SNPs (rs2297743, rs11187096,
rs2488073 and rs7918084) were excluded because of deficiencies
in probes design in the chip and the SNP rs6583826 was excluded
10q23.33 Variants and Type 2 Diabetes
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rate for the remaining 14 SNPs was 98.9%, with a call rate
.97.0% for each locus.
In the replication stage with 1,725 type 2 diabetes cases and
2,081 controls, iPLEX Sequenom MassARRAY platform (Seque-
nom, Inc) was used to genotype the 11 SNPs that were significant
in the discovery stage. Genotyping was conducted blindly and two
NTCs in each 384-sampleplate were used for quality control. The
overall call rate of this stage was 99.4%, with a call rate .99%
individually.
Except for rs7078243 in the discovery stage (P=0.048) and
rs11187094 in the replication stage (P=0.002), the genotype
distribution of other SNPs were all in Hardy-Weinberg equilib-
rium.
Statistical analyses
x
2 or Student’s t tests were used to examine the differences in
the distributions of characteristics between type 2 diabetes cases
and controls. Hardy-Weinberg equilibrium was tested using a
likelihood ratio test. LD between SNPs was evaluated using
Haploview version 4.2. Genotype distributions between cases and
controls were compared using logistic regression under the
additive genetic model with adjustment for age, sex and BMI as
confounding factors. The combined effect of multiple SNPs on the
risk of type 2 diabetes was determined by logistic regression after
categorizing the participants into groups according to the number
of the risk alleles carried. Individuals with no risk alleles served as
the reference group. Cochran’s x
2 -based Q-statistic was
performed to assess heterogeneity in subgroups. Meta-analysis of
9 studies [10–17 and this study] in Chinese populations was
conducted to estimate the pooled effect size. Heterogeneity of the 9
studies was assessed with the Cochran’s x
2 -based Q-statistic. The
random-effects model was adopted when heterogeneity existed;
otherwise the fixed-effects model was appropriate. Combined ORs
were calculated using the Mantel-Haenszel (fixed-effects) and
DerSimonian and Laird (random-effects) tests [21,22]. The
significant P value of overall ORs was determined using the Z-
test. All analyses were performed using the PLINK 1.07 and Stata
software (version 11.1; StataCorp LP, College Station, Texas).
Results
The characteristics of the study populations are presented in
Table 1. No significant differences were observed in the
distributions of sex in both stages and the combined analysis
(P.0.05). Type 2 diabetes cases were in a higher age than controls
(P,0.01) and had significantly higher levels of BMI, FBG,
triglycerides (TG), total cholesterol (TC) and significantly lower
level of high density lipoprotein-cholesterol (HDL-C) as compared
with controls in both stages and combined all (P,0.0001).
Among the 14 SNPs analyzed in the first stage (Table 2), 11
SNPs were associated with type 2 diabetes risk with a P value less
than 0.05, including rs4646957, rs7910605, rs11187094,
rs7078243, rs7911264, rs1111875, rs5015480, rs11187146,
rs7923837, rs2488075, and rs947591. The 11 suggestive SNPs
were further to be tested in the second stage with additional 1,725
type 2 diabetes cases and 2,081 controls. As shown in Table 2,
there were 7 SNPs (rs4646957, rs1111875, rs5015480,
rs11187146, rs7923837, rs2488075, and rs947591) showed similar
associations as observed in the first stage and had a P value less
than 0.05. We further combined the results of two stages for the 7
SNPs that were consistently associated with type 2 diabetes in both
stages (P,0.05). As presented in Table 3, all of the 7 SNPs showed
significant associations with type 2 diabetes risk with effect size
(OR) ranging from 1.14 to 1.33. The most significant locus was
rs7923837 after the two stages were combined with an OR of 1.33
(95% CI: 1.21–1.47).
As shown in Figure S2, a moderate LD (r
2: 0.19–0.64) is
indicated between the most significant SNP rs7923837 and the
other 6 SNPs (i.e. rs4646957, rs1111875, rs5015480, rs11187146,
rs2488075 and rs947591) that were consistently associated with
the risk of type 2 diabetes in the present study. After being
conditioned by rs7923837, rs1111875 was the only SNP still with a
P value,0.05 (Table 4), suggesting that the effect of rs1111875
could not be fully explained by rs7923837. In contrast, the SNP
rs7923837 remained significant after being conditioned by any of
the other SNPs (Table 4). We then combined rs1111875 and
rs7923837 genotypes to test their joint effects on type 2 diabetes
risk. A significant increased risk of type 2 diabetes was detected as
the number of risk alleles increased (P for trend=4.1E-10,
Table 5). Compared to those without carrying any risk allele,
individuals carrying one, two, and three or four risk alleles had a
1.27, 1.44 and 1.73-fold increased risk for developing type 2
diabetes, respectively, while individuals carrying one or more risk
alleles had a 1.39-fold increased risk for type 2 diabetes.
Stratification analyses using pooled case-control sets in additive
genetic model showed that the associations between the two SNPs
(rs1111875 and rs7923837) and type 2 diabetes risk were
significant in subgroups stratified by age, sex, BMI, or stage, with
ORs ranging from 1.15 to 1.44, and the associations had no
significant difference between the subgroups (P.0.05 for hetero-
geneity test, Table S1).
To estimate the pooled effect size of IDE-KIF11-HHEX variants
on type 2 diabetes risk, we conducted a meta-analysis of the three
reported SNPs (rs1111875, rs5015480 and rs7923837) in a total of
14,141 cases and 15,725 controls for rs1111875, 9,208 cases and
11,363 controls for rs5015480, and 8,184 cases and 10,358
controls for rs7923837, respectively, in Chinese populations [10–
17 and this study]. There was no heterogeneity of ORs across
studies of rs1111875 and rs5015480, but there lied heterogeneity
among studies of rs7923837 (P=0.044). The pooled ORs for type
2 diabetes were significant for rs1111875 (pooled OR=1.16, 95%
CI=1.11–1.20, P,0.0001), rs5015480 (pooled OR=1.18, 95%
CI=1.11–1.25, P,0.0001) in the fixed-effects model, and for
rs7923837 (pooled OR=1.19, 95% CI=1.08–1.30, P,0.0001) in
the random-effects model (Figure S3).
Discussion
The current study represents the first fine-mapping study with
an effort to comprehensively investigate the relationship between
IDE-KIF11-HHEX locus and type 2 diabetes risk in this Chinese
population. This is also the largest study in terms of sample size in
a Chinese population to date. We confirmed the associations of
genetic variants at IDE-KIF11-HHEX gene region with risk of type
2 diabetes in Chinese Han population. The tagging SNP
rs7923837 was found to be the variant with the strongest effect
in our population, whereas rs1111875 showed an independent
effect on type 2 diabetes that could not be fully interpreted by
rs7923837. These findings provide new insights into the genetic
variants at IDE-KIF11-HHEX and susceptibility of type 2 diabetes,
and allow for a more stable estimation of effect size on this locus
facilitating genetic risk prediction in the future.
Since Sladek et al firstly reported the association of genetic
variants at IDE-KIF11-HHEX with type 2 diabetes risk in 2007 [3],
several studies have replicated the significant association in
Chinese population [10–16]. Among those studies, the SNP
rs1111875 was included in six studies and the reported ORs
10q23.33 Variants and Type 2 Diabetes
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rs7923837 all reported a higher effect size with ORs of 1.20–1.45
[10,13,16] in Chinese population, which was also found in
Japanese [23] and European ancestry [24] populations. In the
meta-analysis of 22 studies dealing with the relationship between
the HHEX polymorphism and type 2 diabetes in different
ethnicities including Asian, Caucasian, Indian and African
American, the summary per-allele OR for type 2 diabetes of the
rs1111875 and rs7923837 polymorphism was 1.20 (95% CI: 1.16–
1.24), 1.26 (95% CI: 1.19–1.33) in Asians, and 1.16 (95% CI:
1.10–1.23), 1.22 (95% CI: 1.15–1.29) in Europeans, respectively
[24]. In addition, SNP rs5015480 was also investigated in 4 studies
[10,12,13,16], with the ORs being from 1.08 to 1.32 in Chinese
population. In our meat-analysis, the pooled ORs for type 2
diabetes of the rs1111875, rs5015480 and rs7923837 were 1.16
(95% CI: 1.11–1.20), 1.18 (95% CI: 1.11–1.25) and 1.19 (95% CI:
1.08–1.30), respectively. Our findings in this study were consistent
with these results and confirmed that IDE-KIF11-HHEX locus was
one of the susceptibility regions of type 2 diabetes and rs7923837
represented the strongest signal in this region.
We observed a partially independent effect for rs7923837 and
rs1111875 on type 2 diabetes in our population. These two loci
were in modest LD in our population (r
2=0.20), and similar
results were also showed in other Eastern Asian populations
Table 1. Characteristics of the study populations.
Variables Stage I Stage II Combined all
Case Control P Cases Controls P Cases Controls P
n (% male) 1200 (39.8) 1200 (39.8) 0.980 1725 (35.9) 2081 (36.3) 0.805 2925 (37.5) 3281 (37.6) 0.953
Age (years) 57.4369.77 56.4368.02 0.006 58.77610.31 56.66610.81 1.1E-9 58.21610.11 56.5769.88 1.2E-10
BMI (kg/m
2)
a 24.9263.42 22.6462.87 6.6E-66 25.1363.55 21.8262.44 7.9E-220 25.0563.50 22.1262.63 1.2E-275
FBG (mmol/l)
b 8.9863.52 4.5160.47 4.4E-306 9.0763.30 4.5360.56 ,0.001
f 9.0363.52 4.5260.53 ,0.001
f
TG (mmol/l)
c 2.5562.46 1.3260.45 5.2E-62 2.5862.48 0.9660.39 9.7E-170 2.5762.47 1.0960.45 6.4E-227
TC (mmol/l
d 5.3961.62 4.6460.71 1.2E-46 4.7061.23 4.2660.82 2.0E-38 4.9861.44 4.3960.80 3.7E-85
HDL-C (mmol/l)
e 1.3760.34 1.5360.31 7.5E-30 1.5160.55 1.6860.40 3.6E-26 1.4660.48 1.6260.38 2.0E-51
Data are means 6 SD or numbers (percentage).
abody mass index (BMI),
bfasting blood glucose (FBG),
ctriglycerides (TG),
dtotal cholesterol (TC),
ehigh density lipoprotein-cholesterol (HDL-C),
fP value is too small to be shown using Stata software.
doi:10.1371/journal.pone.0035060.t001
Table 2. Summary results of associations between 14 tagging SNPs at 10q23.33 and risk of type 2 diabetes in two stages.
Major Stage I (Ncase/control=1,200/1,200) Stage II (Ncase/control=1,725/2,081)
SNP Position Location
/minor
allele MAFcase/control
a OR (95%CI)
b P
b MAFcase/control
a OR (95%CI)
b P
b
rs4646957 94219892 IDE (intron) C/T 0.256/0.224 1.22 (1.06–1.41) 0.007 0.250/0.231 1.16 (1.02–1.31) 0.023
rs7910605 94229773 IDE (intron) A/G 0.181/0.160 1.20 (1.02–1.41) 0.033 0.175/0.161 1.12 (0.97–1.29) 0.119
rs10882084 94319093 intergene A/G 0.106/0.093 1.21 (0.98–1.49) 0.073 – – –
rs11187083 94342485 KIF11 (59 near
gene)
A/T 0.111/0.109 1.06 (0.87–1.29) 0.553 – – –
rs11187094 94358158 KIF11 (intron) A/G 0.463/0.418 1.26 (1.11–1.42) 3.0E-4 0.405/0.396 1.05 (0.95–1.17) 0.339
rs7078243 94404243 KIF11 (39UTR) C/A 0.202/0.157 1.42 (1.20–1.67) 3.0E-5 0.181/0.168 1.08 (0.94–1.24) 0.297
rs7911264 94426831 intergene C/T 0.241/0.199 1.34 (1.15–1.56) 1.5E-4 0.224/0.208 1.09 (0.96–1.24) 0.184
rs1111875 94452862 intergene T/C 0.299/0.251 1.33 (1.16–1.53) 4.8E-5 0.285/0.261 1.15 (1.02–1.30) 0.019
rs5015480 94455539 intergene T/C 0.186/0.160 1.27 (1.08–1.49) 0.005 0.184/0.163 1.23 (1.07–1.42) 0.004
rs11187146 94468335 intergene C/G 0.358/0.331 1.14 (1.01–1.30) 0.042 0.350/0.325 1.14 (1.02–1.28) 0.018
rs7923837 94471897 intergene A/G 0.235/0.194 1.33 (1.15–1.54) 1.7E-4 0.235/0.199 1.34 (1.18–1.52) 1.0E-5
rs2488075 94480154 intergene T/C 0.169/0.139 1.32 (1.12–1.56) 0.001 0.171/0.140 1.34 (1.15–1.55) 1.1E-4
rs947591 94485733 intergene C/A 0.185/0.158 1.28 (1.09–1.50) 0.003 0.187/0.162 1.21 (1.06–1.40) 0.007
rs4933236 94488416 intergene C/T 0.340/0.322 1.09 (0.95–1.23) 0.214 – – –
aMinor allele frequency (MAF) in cases and controls.
bOdds ratio (OR) and P value derived from logistic regression with a adjustment for age, sex and BMI assuming a additive genetic model.
doi:10.1371/journal.pone.0035060.t002
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for population of European descent (r
2=0.687). The difference in
terms of genotype frequency was also evident between Chinese
(0.194 and 0.251 for rs7923837-G allele and rs1111875-C allele,
respectively) and European ancestry populations (0.592 and 0.658
for rs7923837-G allele and rs1111875-C allele, respectively).
These points suggest a marked genetic difference between
ethnicities. Importantly, a cumulative effect was observed when
the genotypes of rs7923837 and rs1111875 were combined to be
analyzed with type 2 diabetes risk, which would be important to
accurately estimate the risk of type 2 diabetes using genetic
markers in the future.
In this fine-mapping study, we identified the most significant
signal of rs7923837 and additional independent signal of
rs1111875, both of which are located at the telomeric end of a
290-kb LD block on chromosome 10. As shown in Figure S1, these
two SNPs are both in the 39-flanking region of HHEX gene. The
HHEX gene encodes a transcription factor that is involved in Wnt
signaling, a fundamental pathway for cell growth and development
[25], and has been shown to regulate b-cell development and/or
function through the activation of hepatocyte nuclear factor 1a
[26]. Recently, Pivovarova et al. found that rs7923837 and
rs1111875 were associated with altered capacity of b-cell secretion
and proposed that genetic variants at IDE-KIF11-HHEX locus
might mediate the type 2 diabetes risk by modulating b-cell
secretary capacity and b-cell mass [27]. Several studies also
reported associations between rs1111875 and rs7923837 and
fasting insulin secretion, insulin sensitivity and insulin secretion
response following a glucose load [28–32]. Therefore, HHEX was
suggested as the most likely causal candidate gene at 10q23.33 for
type 2 diabetes [33]. Nevertheless, IDE is also another strong
candidate gene. Reduction of IDE activity by a pharmacological
inhibitor increases islet amyloid polypeptide (amylin) accumulation
and amylin-mediated cytotoxicity in cultured b-cells [19] and IDE
ablation causes glucose intolerance in knockout mice [20]. To
now, it is still hard to say which genetic variant(s) in this locus is
(are) causal and how they function in the pathogenesis of type 2
diabetes, though our findings provide additional evidence to refine
the potential functional variants. Further functional and resequen-
cing studies are warranted to clarify the biological mechanisms of
IDE-KIF11-HHEX locus on type 2 diabetes and to identify
additional variants to narrow down the fine-mapped region.
In summary, our fine-mapping study with a two-stage case-
control design and large sample size confirmed the association of
IDE-KIF11-HHEX locus at 10q23.33 with susceptibility to type 2
diabetes. Our results suggest that tagging SNP rs7923837 may
represent the most significant signal in this region in Chinese Han
population.
Table 3. Combined results for 7 SNPs consistently associated with type 2 diabetes risk in two stages.
SNP Case Control
Heterozygote vs. major
homozygote
b
Minor homozygote vs.
major homozygote
b Additive model
b
(n=2925)
a (n=3281)
a OR (95%CI) P OR (95%CI) P OR (95%CI) P
rs4646957 5.86/38.76/55.38 5.39/34.92/59.69 1.26 (1.12–1.42) 1.3E-4 1.22 (0.95–1.56) 0.115 1.18 (1.08–1.30) 3.8E-4
rs1111875 7.88/42.31/49.81 6.80/37.92/55.28 1.31 (1.17–1.48) 5.7E-6 1.36 (1.09–1.69) 0.007 1.23 (1.13–1.35) 5.4E-6
rs5015480 2.83/31.31/65.86 2.61/27.17/70.22 1.33 (1.17–1.50) 8.7E-6 1.20 (0.85–1.70) 0.303 1.25 (1.12–1.39) 4.4E-5
rs11187146 12.38/45.92/41.69 11.04/43.44/45.52 1.18 (1.05–1.33) 0.007 1.27 (1.06–1.53) 0.011 1.14 (1.05–1.24) 0.002
rs7923837 5.38/36.22/58.40 3.90/31.71/64.39 1.37 (1.21–1.54) 3.8E-7 1.66 (1.27–2.18) 2.6E-4 1.33 (1.21–1.47) 6.8E-9
rs2488075 2.69/28.66/68.65 1.90/24.13/73.97 1.36 (1.20–1.55) 2.2E-6 1.60 (1.09–2.33) 0.016 1.33 (1.19–1.49) 3.7E-7
rs947591 3.24/30.80/65.96 2.39/27.37/70.24 1.25 (1.11–1.42) 3.8E-4 1.53 (1.08–2.15) 0.016 1.25 (1.12–1.39) 4.3E-5
aFrequency of minor homozygote/heterozygote/major homozygote.
bAdjusting for age, sex and BMI.
doi:10.1371/journal.pone.0035060.t003
Table 4. Pairwise conditional analysis for 7 SNPs at 10q23.33 consistently associated with type 2 diabetes risks in additive genetic
model.
SNP
a rs4646957 rs1111875 rs5015480 rs11187146 rs7923837 rs2488075 rs947591
rs4646957 - 0.325 0.014 0.004 0.232 0.013 0.004
rs1111875 0.003 - 0.029 9.2E-5 0.032 9.3E-4 1.5E-4
rs5015480 0.002 0.249 - 0.002 0.689 0.031 0.004
rs11187146 0.023 0.026 0.174 - 0.106 0.863 0.355
rs7923837 2.9E-6 2.2E-5 5.8E-5 2.6E-7 - 0.004 4.1E-5
rs2488075 8.6E-6 2.8E-5 1.7E-4 2.8E-5 0.462 - 0.003
rs947591 3.2E-4 5.4E-4 0.003 0.006 0.846 0.627 -
aP value shown in each cell represents the SNP in the row adjusting for age, sex, BMI and the SNP in the corresponding column. For instance, P value of 0.325 for
rs4646957 was adjusted for age, sex, BMI and rs1111875.
doi:10.1371/journal.pone.0035060.t004
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Figure S1 The 290-kb linkage disequilibrium analysis
on 10q23.33 and tagging single-nucleotide polymor-
phisms (chr10:94199856–94489557). The IDE-KIF11-HHEX
locus at 10q23.33 (chr10:94199856–94489557) splits into 5 linkage
disequilibrium (LD) blocks in Asians (Chinese & Japanese). 19
single-nucleotide polymorphisms (SNPs) (seen at the black arrows)
were selected for genotyping in the discovery stage, including 13
haplotype-tagging SNPs (htSNP), chosed with criteria of minor
allele frequency (MAF)$0.10, Hardy-Weinberg equilibrium
P$0.05, and call rate $95%) on the basis of pairwise LD r
2
threshold of 0.8, 3 potentially functional SNPs and 3 SNPs
previously reported by GWAS of type 2 diabetes.
(DOC)
Figure S2 Linkage disequilibrium analysis of 7 single-
nucleotide polymorphisms consistently associated with
type 2 diabetes risks. Linkage disequilibrium (LD) strength in
controls was shown in the diamonds represented by r
2 values. A
moderate LD (r
2: 0.19–0.64) was indicated between the most
significant SNP rs7923837 and the other significant 6 SNPs, with
r
2 value being 0.19 for rs4646957, 0.20 for rs1111875, 0.43 for
rs5015480, 0.50 for rs11187146, 0.64 for rs2488075, 0.46 for
rs947591 respectively.
(DOC)
Figure S3 Meta-analysis of 3 single-nucleotide polymor-
phisms from IDE-KIF11-HHEX locus with type 2 diabe-
tes in Chinese populations. The pooled odds ratios (ORs) for
type 2 diabetes were significant for rs1111875 (pooled OR=1.16,
P,0.0001), rs5015480 (pooled OR=1.18, P,0.0001) in the fixed-
effects model, and for rs7923837 (pooled OR=1.19, P,0.0001) in
the random-effects mode.
(DOC)
Table S1 Stratification analysis for two independent
SNPs (rs7923837 and rs1111875) and risk of type 2
diabetes in additive genetic model.
(DOC)
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